Divi's Laboratories

Price chart

Previous close

₹11,097.00

Open

₹11,135.50

Day high

₹11,824.00

Day low

₹11,071.00

Listed on NSE since 12 March 2003.

Futures and options

Futures, 23 Nov expiry

₹11,483.50

Premium to the share price

+33.50 (+0.29%)

Futures open interest

58,960 contracts (−1,665 today)

Lot size (NOV 26)

100 shares

Source: NSE, 09-Nov-2026 12:04:08, delayed. Option chain · All futures · Lot sizes

Pivot levels

R3

10,693.83

R2

10,507.17

R1

10,413.83

CPR top

10,273.83

Pivot

10,227.17

CPR bottom

10,180.50

S1

10,133.83

S2

9,947.17

S3

9,853.83

From Friday 6 November’s high, low and close (Yahoo Finance). Arithmetic on past prices, not a forecast.

Market value

₹3,10,638 Cr

P/E (trailing)

99.28

EPS (trailing)

₹117.86

Price to book

17.25

Return on equity

20.1%

Debt to equity

0.00

Profit margin

27.6%

Beta

0.18

Volume today

18.88 L

Average volume

5.40 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Source: Divi's Laboratories’s results filed with NSE, consolidated (the whole group). Net profit is the share of Divi's Laboratories’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Source: Divi's Laboratories’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as astaxanthin, beta-carotene, lycopene, canthaxanthin, apocarotenal, and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.

Industry

Drug Manufacturers - Specialty & Generic

Based in

Hyderabad

Employees

11,565

Company website · Profile: Yahoo Finance

• Divi's Laboratories shares hit record high rising 84% YTD; buy, sell or hold after Q2 results 2026? Brokerages report

  Mint · 9 Nov, 10:18

• Divi's Laboratories shares gain 6% after JPMorgan upgrade; Goldman raises earnings estimates after strong Q2

  CNBC-TV18 · 9 Nov, 09:32

• Dividend - Rs 30 Per Share

  Dividend · ex-date 24 July 2026

• Dividend - Rs 30 Per Share

  Dividend · ex-date 25 July 2025

• Dividend - Rs 30 Per Share

  Dividend · ex-date 2 August 2024

• Dividend - Rs 30 Per Share

  Dividend · ex-date 11 August 2023

• Dividend - Rs 30 Per Share

  Dividend · ex-date 11 August 2022 · record date 12 August 2022

• Dividend - Rs 20 Per Share

  Dividend · ex-date 17 August 2021

• Annual General Meeting

  Action · ex-date 4 September 2020

• Interim Dividend - Rs 16 Per Share

  Dividend · ex-date 25 February 2020 · record date 26 February 2020

Source: NSE. Latest first, 8 of 20.